Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 21;12(1):9-14.
doi: 10.9740/mhc.2022.01.009. eCollection 2022 Jan.

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis

Julie Nguyen  1   1   2 , Stephen Lee  1 , Dennis Ankrah  1 , Erin Knox  2
Affiliations

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis

Julie Nguyen et al. Ment Health Clin. .

Abstract

Background: Methamphetamine is an addictive stimulant that may induce symptoms of agitation and psychosis. The estimated rate of methamphetamine use is 6.6 per 1000 people. Currently, no treatment guidelines exist to support the optimal management of patients presenting with methamphetamine-induced agitation. Emergency department (ED) providers may prescribe various benzodiazepines (BZDs) and antipsychotics (APs) as first-line agents to stabilize these agitated patients. This study aims to determine the effectiveness of a protocol to guide management of this condition.

Methods: This was a retrospective, pre- and poststudy conducted from July 2020 to March 2021 at a large academic medical center. A multidisciplinary protocol was designed to help manage methamphetamine-induced agitation in the ED. The primary outcome of the study was a reduction in the number of BZDs and APs used for the treatment of methamphetamine-induced agitation. This was measured by the incidence of overprescribing, defined as 3 or more APs or BZDs administered within 30 minutes. Secondary outcomes included the use of physical restraints, ED length of stay, and adverse events.

Results: We did not observe a significantly lower incidence of overprescribing, adverse events, or ED length of stay when comparing pre- and postprotocol groups. A subgroup analysis demonstrated that when protocol was followed, there was a statistically significant reduction in overprescribing (P = .001).

Discussion: We did not find any differences among our primary and secondary outcomes, which may be attributed to protocol nonadherence. Full compliance to the protocol may reduce the rate of overprescribing APs or BZDs in patients with methamphetamine-induced agitation.

Keywords: acute agitation; agitation; antipsychotics; benzodiazepines; emergency room; methamphetamine; methamphetamine induced agitation; methamphetamine psychosis; stabilization; substance use.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have no disclosures.

Figures

FIGURE 1
FIGURE 1
Our institution's methamphetamine protocol (bid = twice a day; ODT = oral disintegrating tablet; tid = three times a day)
FIGURE 2
FIGURE 2
Influence of protocol on overprescribing
See this image and copyright information in PMC

References

    1. Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, et al. Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry. 2012;12(1):221. 10.1186/1471-244X-12-221 PubMed PMID: 23216941 PubMed Central PMCID: PMC3554477. - DOI - PMC - PubMed
    1. Jones CM, Compton WM, Mustaquim D. Patterns and characteristics of methamphetamine use among adults--United States, 2015–2018. MMWR Morb Mortal Wkly Rep. 2020;69(12):317–23. 10.15585/mmwr.mm6912a1 PubMed PMID: 32214077 PubMed Central PMCID: PMC7725509. - DOI - PMC - PubMed
    1. Pasic J, Russo JE, Ries RK, Roy-Byrne PP. Methamphetamine users in the psychiatric emergency services: a case-control study. Am J Drug Alcohol Abuse. 2007;33(5):675–86. 10.1080/00952990701522732 PubMed PMID: 17891660. - DOI - PubMed
    1. Winkelman TNA, Admon LK, Jennings L, Shippee ND, Richardson CR, Bart G. Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States. JAMA Netw Open. 2018;1(6):e183758. 10.1001/jamanetworkopen.2018.3758 PubMed PMID: 30646256. - DOI - PMC - PubMed
    1. Wodarz N, Krampe-Scheidler A, Christ M, Fleischmann H, Looser W, Schoett K, et al. Evidence-based guidelines for the pharmacological management of acute methamphetamine-related disorders and toxicity. Pharmacopsychiatry. 2017;50(3):87–95. 10.1055/s-0042-123752 PubMed PMID: 28297728. - DOI - PubMed

LinkOut - more resources